Like Bio-Optronics Group, LLC

closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/25/2021 via Company Press Release

doctari, acquired Planerio

synopsis: doctari, an online specialist healthcare staffing platform in the DACH region, has acquired Planerio, a German intelligent shift scheduling software solution for healthcare providers. Planerio automatically creates optimal schedules based on jobs and employee requests. Their software also features tools for digital time recording, payroll and more.
buyer: doctari
doctari is an online specialist healthcare staffing platform in the DACH region. doctari helps healthcare institutions to find quality doctors and nurses, enabling them to focus more on their business. They offer over 25,000 qualified medical professionals for short and long term positions. "
target: Planerio
Planerio is a German intelligent shift scheduling software solution for healthcare providers. Planerio automatically creates optimal schedules based on jobs, employee requests, and vacations. Their software also features tools for digital time recording, payroll, absence management, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/23/2021 via Company Press Release

Alfa Kommun & Landsting AB and Safe Care Svenska AB, will acquire Clinicbuddy

synopsis: Alfa eCare, an eHealth software group in Sweden, will acquire Clinicbuddy, a Swedish provider of electronic health record solutions for private care institutions. Clinicbuddy provides a SaaS-based solution that enables care providers to run their businesses more efficiently. Their software also provides solutions for payment and patient booking.
buyer parent: Main Capital Partners BV
buyer: Alfa Kommun & Landsting AB and Safe Care Svenska AB (:$0.00)
Alfa Group is a Swedish eHealth software group consisting of Alfa Kommun & Landsting AB and Safe Care Svenska AB. Alfa’s broad offering includes both complete information systems and niche products, such as solutions for journaling, electronic prescription, medication management and care planning. "
target: Clinicbuddy
Clinicbuddy is a Swedish provider of electronic health record solutions for private care institutions. Clinicbuddy provides a SaaS-based solution that enables care providers to run their businesses more efficiently. Their software also provides solutions for payment and patient booking.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/13/2021 via PR Newswire

Millennia Patient Services, acquired Jellyfish Health

synopsis: Millennia, a leader in patient payment solutions for hospitals, health systems, and medical groups, has acquired Jellyfish Health, an innovative provider of patient engagement and patient access software. With the acquisition, Millennia will be able to serve over 1,200 facilities in 42 states.
buyer: Millennia Patient Services
Millennia provides technology-driven patient pay and engagement solutions. Millennia aims to simplify and streamline the patient financial experience by communicating with patients informatively and often through their patient engagement platform and team of highly-trained support specialists. "
target: Jellyfish Health
Jellyfish Health provides a suite of patient access and patient engagement software. The suite is focused on streamlining the patient experience and includes virtual intake, online scheduling, appointment reminders and messaging, digital pre-service forms, and other patient access applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/12/2021 via GlobeNewswire

VitalHub, will acquire Jayex

synopsis: Toronto-based VitalHub Corp. will acquire Jayex Healthcare Limited, a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms. With this acquisition, VitalHub will significantly increase its number of customers using at least one module of its patient journey solutions within the UK and Australia.
buyer: VitalHub (TSXV:VHI:$11.00)
Based in Canada, VitalHub provides technology to Health and Human Services providers designed to simplify the user experience & optimize outcomes. VitalHub solutions span the categories of EHR, case management, care coordination, patient flow & operational visibility, and DOCit mobile apps. "
target: Jayex
Jayex is a leading Australian e-health provider of integrated SaaS healthcare services delivery platforms. Jayex's complete patient engagement program allows businesses to control queue management, patient access, appointment booking, and healthcare campaigns from a single, cloud-based dashboard.
price ($mm)
$1.80
rev ($mm)
$1
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA
announced 3/24/2021 via Company Press Release

Appriss Health, will acquire PatientPing

synopsis: Appriss Health, a leader in cloud-based care coordination software and analytics solutions focused on behavioral health and substance use disorders, will acquire PatientPing, a leader in care coordination data and software solutions focused on patients with complex needs, and senior care.
buyer parent: Insight Venture Partners
buyer: Appriss Health
Appriss Health is a leading SaaS platform for behavioral health care coordination and is a recognized leader in providing software and data analytics solutions to identify and mitigate Substance Use Disorders. "
target: PatientPing
PatientPing is an innovative care collaboration platform that reduces the cost of healthcare and improves patient outcomes by seamlessly connecting providers to coordinate patient care. The platform enables providers to collaborate on shared patients through a comprehensive suite of solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/11/2020 via BNC Analysis

PatientSky, will acquire Infodoc

synopsis: PatientSky Group, a Norwegian company that develops innovative IT solutions for both patients and healthcare practitioners, will acquire Infodoc AS, a leading e-health provider in Norway. Infodoc provides cloud-based electronic health records (EHR) to general practitioners, specialists and public health centres.
buyer: PatientSky (OB:PSKY-ME:$0.00)
PatientSky is a Norwegian company that develops innovative IT solutions for both patients and healthcare practitioners. PatientSky offers a low-code platform for developing high-performant cloud solutions. Their platform allows users to develop faster, reduce R&D costs, and increase scalability. "
target: Infodoc
Infodoc is a leading e-health provider in Norway. Infodoc provides cloud-based electronic health records (EHR) to general practitioners, specialists and public health centres to help them improve their efficiency and patient experience. They also offer invoicing and scheduling solutions.
price ($mm)
$30
rev ($mm)
$6
EBITDA ($mm)
EV / rev
4.9x
EV / EBITDA
closed 10/14/2020 via PR Newswire

Clearwave Inc, acquired Odoro

synopsis: Clearwave, a healthcare industry leader in digital check-in and eligibility verification, announced its acquisition of Odoro, provider of digital patient-access solutions for healthcare providers, physician practices, and healthcare systems.
buyer: Clearwave Inc
Clearwave is a premier digital check-in and eligibility-verification solution provider for the healthcare industry. Since 2004, the company has helped its customers improve the patient experience via a comprehensive technology solution. "
target: Odoro
Odoro provides a patient-scheduling and check-in tool. Their digital patient access platform allows health systems to optimize their scheduling flow for every facet of their organization. Odoro increases patient acquisition and retention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2019 via PR Newswire

Medecision, acquired GSI Health, LLC.

synopsis: Medecision, an integrated health management solutions provider that supports the health and care of more than 50 million consumers nationwide, has acquired Philadelphia-based GSI Health, a SaaS provider of workflow, engagement and compliance solutions and related services.
buyer parent: Health Care Service Corporation
buyer: Medecision
Medecision is an integrated health management solutions provider that supports the health and care of more than 50 million consumers nationwide. Medecision povides Aerial, an integrated health solution with a suite of applications for engagement and workflow. "
target: GSI Health, LLC.
GSI Health is a SaaS provider of workflow, engagement and compliance solutions and related services. The GSI Health platform is used by some of the nation's leading health systems to coordinate and optimize value-based care for more than one million beneficiaries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2019 via BusinessWire

QGenda, acquired OpenTempo

synopsis: QGenda, the leader of cloud-based, automated provider scheduling solutions, announced its acquisition of OpenTempo, a company that provides enterprise clinical capacity management tools, analytics and supporting services to address critical scheduling and capacity issues.
buyer: QGenda
QGenda is the #1 cloud-based, automated provider scheduling software. Leading physician groups, hospitals, academic medical centers, and enterprise health systems use QGenda to optimize their workforce which allows them to provide the best possible patient care. "
target: OpenTempo
OpenTempo provides enterprise clinical capacity management tools, analytics and supporting services to address critical scheduling and capacity issues. OpenTempo supports more than 150 customers and over [25,000 providers]. OpenTempo is headquartered in Burlington, VT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/22/2014 via PR Newswire

AMN Healthcare Services, Inc., acquired Avantas, LLC

synopsis: AMN Healthcare Services, Inc., the nation's leader and innovator in healthcare workforce solutions and staffing services, announced the acquisition of Avantas, a leading provider of clinical labor management services, including workforce consulting, data analytics, predictive modeling and SaaS-based scheduling technology.
buyer: AMN Healthcare Services, Inc. (AHS:$2,677.20)
AMN Healthcare is the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare's workforce solutions enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes. "
target: Avantas, LLC
Avantas is a provider of clinical labor management services, including workforce consulting, data analytics, and SaaS-based scheduling technology. Avantas provides services and technology tools that help clients optimize and plan their clinical workforce to cost-effectively handle patient demand.
price ($mm)
$17
rev ($mm)
$8
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
announced 12/21/2012 via BusinessWire

RelayHealth, will acquire AHI Software, Inc.

synopsis: RelayHealth agreed to acquire Ahi Software, provider of two #1 in KLAS patient access solutions. Ahi Software’s solutions will complement RelayHealth’s patient access solutions and expertise to support providers who seek to streamline their patient access process for more effective reimbursement and enhanced patient engagement and satisfaction.
buyer parent: McKesson Corporation
buyer: RelayHealth
RelayHealth, McKesson’s connectivity business, enables the secure exchange of clinical, financial and administrative information between patients, providers, payers, pharmacies, pharmaceutical manufacturers and government agencies. "
target: AHI Software, Inc.
AHI Software, Inc. provides the Patient Access Department with the necessary tools to improve quality, facilitate data exchange and enhance revenue cycle performance. Their integrated solutions empower hospital revenue cycle teams to outperform industry standards.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/31/2012 via Company Press Release

Allocate Software plc., acquired RealTime Health Ltd

synopsis: Allocate Software has acquired RealTime Health Ltd, the supplier of patient flow software. RealTime’s software is used to improve patient care and financial performance by improving clinical processes which in turn lead to reduced average length of stay and increased inpatient capacity.
buyer: Allocate Software plc. (MSWEF:$25.50)
Allocate Software is the leading workforce optimization software applications provider for global organizations with large, multi-skilled workforces. With years of experience, they ensure customers can match operational demands with workforce supply. "
target: RealTime Health Ltd
RealTime is a system that pro-actively drives the discharge process. It benefits healthcare organisations by reducing Length of Stay by improving the discharge process, delivering financial and administrative benefits, improving clinical processes and reduces variation in practice.
price ($mm)
$1.89
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/12/2012 via PR Newswire

Passport Health Communications, Inc., acquired STAT Technologies Inc.

synopsis: Passport Health Communications Inc. has purchased N.J.-based STAT Technologies, adding enterprise scheduling to its suite of patient access and payment certainty solutions. STAT offers one of the only systems for managing schedules across outpatient, inpatient and surgery areas.
buyer parent: Great Hill Partners LLC
buyer: Passport Health Communications, Inc.
Passport Health Communications Inc. creates solutions to enable hospitals and healthcare providers to improve business operations and achieve Payment Certainty for Every Patient™. The organization is among the nation's fastest-growing Software-as-a-Service companies. "
target: STAT Technologies Inc.
Founded in 1999, STAT Technologies was among the first healthcare technology companies to develop solutions for enterprise scheduling and offers one of the only systems for managing schedules across outpatient, inpatient and surgery areas.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/22/2010 via Company Press Release

iSoft Group Limited, acquired UltraGenda

synopsis: UltraGenda announces alliance with Australia’s largest listed health information technology company, iSOFT Group Limited. Joining forces will allow UltraGenda to bring its solutions to distant markets while iSOFT will enrich its solutions with the strength of our scheduling component.
buyer: iSoft Group Limited
iSOFT is one of the world’s largest providers of healthcare IT solutions. iSoft designs, builds and delivers industry-leading software systems that serve the entire health sector. "
target: UltraGenda
UltraGenda’s mission is to produce the world’s finest IT solutions to support referral and scheduling processes in healthcare, with special emphasis on hospitals, HMO’s and healthcare communities.
price ($mm)
$11
rev ($mm)
$5
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
announced 7/10/2020 via GlobeNewswire

Health Catalyst, will acquire healthfinch

synopsis: Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, is to acquire healthfinch, Inc., a Madison, Wisconsin-based company that provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in real-time.
buyer: Health Catalyst (HCAT:$199.57)
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. The company's customers leverage the cloud-based analytics software data platform to make data-informed decisions and realize measurable clinical, financial, and operational improvements."
target: healthfinch
healthfinch has developed the healthcare industry's most trusted, most used clinical workflow optimization solution, Charlie. Charlie streamlines key workflows such as prescription renewal processing, visit planning, and care gap closure.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2017 via Market Wire

GetWellNetwork, Inc., acquired Seamless Medical Systems

synopsis: GetWellNetwork, Inc., the leader in Interactive Patient Care solutions, announced the acquisition of Seamless Medical Systems, a provider of patient engagement solutions. The acquisition of Seamless extends GetWellNetwork's fully integrated cross-continuum patient engagement platform to more than 150 clinics nationwide.
buyer parent: Welsh, Carson, Anderson & Stowe
buyer: GetWellNetwork, Inc.
GetWellNetwork, Inc. provides patient engagement solutions that help health care providers engage, educate and empower patients along the care continuum. Their platform enables providers to implement a care delivery model called Interactive Patient Care to improve performance and patient outcomes. "
target: Seamless Medical Systems
Seamless Medical Systems has created a patient engagement platform that begins with online scheduling and pre-registration, moves to the point of care with paperless registration, insurance verification and payment; and continues with patient communications, practice marketing and patient surveys.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/6/2012 via Company Press Release

McKesson Corporation, will acquire Emendo Ltd

synopsis: McKesson announced it has entered a definitive agreement to acquire Emendo Ltd., whose CapPlan Predictive Capacity Planning solution equips healthcare providers to optimize operational performance by intelligently forecasting patient demand.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care. "
target: Emendo Ltd
Emendo’s CapPlan solution enables over 40 hospitals throughout New Zealand, Australia, Canada and the UK to forecast patient demand and plan resourcing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/18/2021 via BusinessWire

Verily Life Sciences, will acquire SignalPath

synopsis: Verily, an Alphabet company focused on life sciences and healthcare, will acquire SignalPath, a clinical trial management system (CTMS) that improves the ease and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
buyer parent: Google
buyer: Verily Life Sciences
Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world’s health data useful so that people enjoy healthier lives. The company develops tools to collect and activate health data, and creates interventions to prevent and manage disease. "
target: SignalPath
SignalPath is a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath's CTMS platform ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2021 via BusinessWire

Francisco Partners Management LLC, will acquire STARLIMS

synopsis: Francisco Partners is to acquire the STARLIMS informatics product suite and related business assets from Abbott. A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Francisco Partners has raised approximately $25 billion in committed capital and invested in more than 300 technology companies. "
target parent: Abbott Laboratories
target: STARLIMS (LIMS:$25.24)
A world-class Laboratory Information Management System (LIMS) solution, STARLIMS is a product suite that improves both quality and safety for organizations throughout the entire product lifecycle, beginning with R&D.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/10/2021 via PR Newswire

Advarra, acquired Bio-Optronics Group, LLC

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, has acquired Bio-Optronics, a leading healthcare information technology company. Bio-Optronics offers software solutions for clinical research management, staff scheduling, and patient workflows.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Bio-Optronics Group, LLC
Bio-Optronics is a leading healthcare information technology company. Bio-Optronics helps healthcare professionals to enhance quality, productivity, patient and staff satisfaction. They offer software solutions for clinical research management, staff scheduling, and patient workflows.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/25/2020 via Company Press Release

Advarra, acquired Longboat Clinical Ltd.

synopsis: Advarra, the market leader in regulatory review solutions and clinical site technologies, is pleased to announce the acquisition of Longboat, an innovative provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target: Longboat Clinical Ltd.
Longboat is an innovative provider of user-friendly, fully mobile clinical research technology solutions that take the complexity out of trials for site staff, patients, monitors, and study teams, making protocol compliance easy and instinctive.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/6/2019 via BNC Analysis

Advarra, will acquire Forte Research Systems

synopsis: Advarra, the premier provider of institutional review board, institutional biosafety committee, and research quality and compliance consulting services, will acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems.
buyer parent: Genstar Capital LLC
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Primus
target: Forte Research Systems
Forte provides software and services in the critical areas of clinical trial management, clinical data management, and research administration for cancer centers, academic medical centers, and health systems. Forte's flagship Clinical Trial Management System, OnCore manages clinical research data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2019 via BNC Analysis

Genstar Capital LLC, acquired Advarra

synopsis: Genstar Capital, a private equity firm focused on investments in financial services, healthcare, industrial technology, and software industries, has acquired Advarra, a leading provider of institutional review board, institutional biosafety committee, and research quality and compliance solutions that are critical to the drug development process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that actively invests in high quality companies. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. "
target parent: Linden Capital Partners
target: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2013 via BusinessWire

Audax Group, acquired Chesapeake Research Review

synopsis: Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc. Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems.
buyer: Audax Group
Audax Group, founded in 1999, is a leading investor in lower-middle market companies. With offices in Boston and New York, Audax has over $5 billion in assets under management in its Private Equity, Mezzanine, and Senior Debt businesses. "
target: Chesapeake Research Review
Chesapeake Research Review, Inc. provides human research protections services. It offers institutional review board services & human research protections consultation, including strategic & operational, IRB consultation services; ethical, scientific & applied bioethics review, education & auditing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2019 via BNC Analysis

Genstar Capital LLC, acquired Advarra

synopsis: Genstar Capital, a private equity firm focused on investments in financial services, healthcare, industrial technology, and software industries, has acquired Advarra, a leading provider of institutional review board, institutional biosafety committee, and research quality and compliance solutions that are critical to the drug development process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that actively invests in high quality companies. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. "
target parent: Linden Capital Partners
target: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/11/2019 via PR Newswire

Corrona, Inc., acquired HealthiVibe LLC

synopsis: Corrona, LLC, a leading provider of real-world observational and syndicated registry data, announced that it has acquired HealthiVibe, LLC, a leading patient experience company. HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle.
buyer parent: Great Point Partners
buyer: Corrona, Inc.
Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. "
target: HealthiVibe LLC
HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives of the product lifecycle. They leverage models and online analytic platforms to provide tools to optimize clinical trials and enhance product commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/22/2016 via PR Newswire

The WIRB-Copernicus Group, acquired CenterWatch, Inc.

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information. CenterWatch provides clinical trials information to clinical research professionals.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
target: CenterWatch, Inc.
CenterWatch is the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs, to investigative sites, technology solutions and niche providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2016 via PR Newswire

Nordic Capital, will acquire ERT

synopsis: Genstar Capital, a leading private equity firm focused on the healthcare, software, financial services, and industrial technology industries, announced the sale of ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, to Nordic Capital Fund VIII.
buyer: Nordic Capital
Nordic Capital is a leader in Nordic private equity investments, and now has an enviable reputation in investment and portfolio management. Since launching in 1989, Nordic Capital funds have delivered outstanding returns for our investors. "
target parent: Genstar Capital LLC
target: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions.
price ($mm)
rev ($mm)
$300
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 7/3/2012 via PR Newswire

Genstar Capital LLC, acquired ERT

synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations, announced that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction.
buyer: Genstar Capital LLC
Genstar Capital LLC has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, software and software services, insurance and financial services, and industrial technology industries. "
target: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives.
price ($mm)[EV]
$395 [$370]
rev ($mm)
$194
EBITDA ($mm)
$42
EV / rev
1.9x
EV / EBITDA
9.0x
closed 5/5/2010 via Company Press Release

Kenneth Getz, acquired CenterWatch, Inc.

synopsis: Ken Getz, the founder of CenterWatch—an industry-leading clinical trials information services company—along with private equity investors has purchased the company from Jobson Medical Information.
buyer: Kenneth Getz
Ken Getz founded CenterWatch in 1994 and established the company as a leading provider of operating and business information on the $40 billion global clinical trials industry. Getz sold the company to the Thomson Corporation in 1998. "
target parent: Wicks Group of Companies
target: CenterWatch, Inc.
CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites, data about the global clinical trials industry and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/31/2007 via Berkery

Jobson Medical Information LLC, acquired CenterWatch, Inc.

synopsis: The Thomson Corporation announced the sale of CenterWatch to Jobson Medical Information, a portfolio company of The Wicks Group, LLC. CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
buyer parent: The Wicks Group of Companies, L.L.C.
buyer: Jobson Medical Information LLC
Jobson Medical Information is a leading specialty healthcare communications, publishing, and medical education company. Jobson Medical Information produces a broad range of publications, educational programs, enduring educational materials, live events, symposia and websites. "
target parent: Thomson Corporation
target: CenterWatch, Inc.
CenterWatch is a trusted source and global leader in providing proprietary data and information about clinical trials to both professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2020 via PR Newswire

Arsenal Capital Partners, acquired BresMed Health Solutions Ltd

synopsis: Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
buyer: Arsenal Capital Partners
Arsenal is a leading private equity firm that specializes in investments in middle‐market specialty industrials and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of $5.3 billion, and completed more than 45 platform investments. "
target: BresMed Health Solutions Ltd
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. Established in 2006, BresMed has more than 150 staff across offices in the U.K., Ireland, the Netherlands, the U.S., and India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/22/2020 via PR Newswire

Clarivate Analytics, will acquire Decision Resources Group

synopsis: Clarivate Analytics plc, a global leader in providing trusted insights and analytics, will acquire Decision Resources Group ("DRG"), a premier provider of high-value data, analytics and insights products and services to the healthcare industry, from Piramal Enterprises Limited, part of global business conglomerate Piramal Group.
buyer: Clarivate Analytics (:$1,614.03)
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management. "
target parent: Piramal Group
target: Decision Resources Group
Decision Resources Group (DRG) is uniquely positioned to help healthcare businesses improve the lives of patients around the world by creating patient-centric commercial strategies that drive better outcomes and better access.
price ($mm)
$950
rev ($mm)
$207
EBITDA ($mm)
$48
EV / rev
4.6x
EV / EBITDA
20.0x
closed 8/16/2017 via PR Newswire

Decision Resources Group, acquired Context Matters

synopsis: Decision Resources Group announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Context Matters
Context Matters is led by a team with extensive experience in the pharma & biotech and financial & information sectors with deep operational familiarity of the issues facing the pharmaceutical industry and those following the industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 12/4/2012 via BusinessWire

Decision Resources Group, acquired Abacus International

synopsis: Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced that it has acquired Abacus International, a pioneer in evidence-based global market access solutions for many of the world’s leading healthcare companies.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Abacus International
Abacus International is unique in its provision of services throughout the lifecycle of a pharmaceutical or medical device. They can provide tailored solutions to overcome each hurdle of the product development process, from pre-launch though to market access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/10/2007 via

Providence Equity Partners Inc., acquired Decision Resources, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced today that Providence Equity Partners, a leading private equity firm with more than $21 billion under management, will acquire majority control of the Company.
buyer: Providence Equity Partners Inc.
Providence Equity Partners Inc. is a private investment firm specializing in equity investments in communications and media companies around the world. The principals of Providence Equity manage funds with approximately $21 billion in equity commitments. "
target parent: Boston Ventures Management, Inc.
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2004 via PR Newswire

Boston Ventures Management, Inc., Castanea Partners, acquired Decision Resources, Inc.

synopsis: Castanea Partners and Boston Ventures Limited Partnership VI today announced the recapitalization of Decision Resources, Inc., with a total transaction value of $58 million. The Waltham, Massachusetts-based company is best known for its therapeutically-focused analyses of global pharmaceutical and biotechnology markets.
buyer: Boston Ventures Management, Inc.
buyer: Castanea Partners
Boston Ventures Management, LLC is a private equity firm that has been an active investor and financial partner to management teams in the media, entertainment, publishing and information and communications sectors since 1983, earning the firm a franchise position in the private equity community. "
target: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2015 via BNC Analysis

Sudler & Hennessey, acquired System Analytic Ltd.

synopsis: Sudler & Hennessey, has acquired a majority stake in System Analytic for an undisclosed sum. Sudler is a global healthcare marketing and communications network, while London-based System Analytic’s database and online tools enable pharmaceutical companies to identify, map and engage key opinions leaders across a broad range of medical fields.
buyer parent: WPP Group, plc
buyer: Sudler & Hennessey
Sudler & Hennessey is one of the world's leading healthcare communications firms, developing strategic promotional and educational programmes for a broad array of healthcare brands. "
target: System Analytic Ltd.
System Analytic Ltd. owns and operates a database and online tools to help pharmaceutical companies to identify and engages opinion leaders. The company was incorporated in 2006 and is based in London, United Kingdom.
price ($mm)
rev ($mm)
$3
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 12/19/2019 via BusinessWire

Audax Group, acquired Corrona, Inc.

synopsis: Audax Private Equity announced that it has recapitalized, in partnership with the management team, Corrona, LLC. Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators.
buyer: Audax Group
Audax Group is a leading alternative investment manager with offices in Boston, New York, and San Francisco. Since its founding in 1999, the firm has raised over $24 billion in capital across its Private Equity and Private Debt businesses. "
target parent: Great Point Partners
target: Corrona, Inc.
Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/10/2009 via BusinessWire

United BioSource Corporation, acquired Cognitive Drug Research, Ltd.

synopsis: United BioSource Corporation (UBC) announced the acquisition of Cognitive Drug Research, Ltd. (CDR), the leader in computerized cognitive testing for clinical trials. The CDR System is the most widely used computerized cognitive testing system in the world: it is used in more than 1000 trials encompassing approximately 50 different disease areas.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Cognitive Drug Research, Ltd.
Cognitive Drug Research, Ltd. (CDR) is the world leader in automated cognitive function assessment in phase I through phase IV clinical trials. Founded by Keith Wesnes in 1986, CDR’s proprietary cognitive assessment system can be administered to virtually any patient population in any environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2015 via PR Newswire

Precision for Value, acquired Redwood Outcomes

synopsis: Precision for Value, a company that supports commercial excellence for global pharmaceutical and life sciences clients through the demonstration and communication of product value and outcomes, announced its acquisition of Redwood Outcomes, a leading international health economics and outcomes research company.
buyer parent: Precision for Medicine
buyer: Precision for Value
Precision for Value supports excellence for global pharmaceutical and life sciences clients through the communication of product value and outcomes. The Precision for Value teams provide clients with services of industry knowledge, demonstrated analytics proficiency, and communications prowess. "
target: Redwood Outcomes
Redwood Outcomes is a Health Economics & Outcomes Research firm. They aim to advance and apply the science of evidence synthesis, integration, and communication to optimize health care decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/8/2017 via GlobeNewswire

PRA Health Sciences, will acquire Symphony Health Solutions

synopsis: PRA Health Sciences, Inc. (“PRA”), a leading clinical research organization, announced it has signed a definitive agreement to acquire Symphony Health Solutions Corporation (“Symphony Health”), a privately-held best-in-class provider of data, analytics and consulting solutions to the life sciences market.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences is one of the world’s leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: Symphony Technology Group
target: Symphony Health Solutions
Symphony Health Solutions is a leading provider of high-value data, analytics, and technology solutions for biopharmaceutical manufacturers, healthcare providers, and payers. Symphony Health derived data improves health management decisions, and helps clients drive revenue growth.
price ($mm)
$530
rev ($mm)
$200
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA

Like Bio-Optronics Group, LLC


read more

Bio-Optronics Group, LLC

Planerio

Clinicbuddy

Jellyfish Health

Jayex

PatientPing

Infodoc

Odoro

GSI Health, LLC.

OpenTempo

Avantas, LLC

AHI Software, Inc.

RealTime Health Ltd

STAT Technologies Inc.

UltraGenda

healthfinch

Seamless Medical Systems

Emendo Ltd

SignalPath

STARLIMS

read more

Bio-Optronics Group, LLC

read more

Bio-Optronics Group, LLC

Longboat Clinical Ltd.

Forte Research Systems

Advarra

Kinetiq

Chesapeake Research Review

read more

Advarra

HealthiVibe LLC

CenterWatch, Inc.

ERT

ERT

CenterWatch, Inc.

CenterWatch, Inc.

BresMed Health Solutions Ltd

Decision Resources Group

Context Matters

Avalere Health LLC

Abacus International

Decision Resources Group

Decision Resources, Inc.

Decision Resources, Inc.

System Analytic Ltd.

Corrona, Inc.

Cognitive Drug Research, Ltd.

Redwood Outcomes

Symphony Health Solutions

Geography
Matching Companies
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$30.36
EBITDA ($mm)
$5.22
EBIT ($mm)
$2.50
Net Income ($mm)
Employees
225
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,109.32
EBITDA ($mm)
$197.54
EBIT ($mm)
$138.73
Net Income ($mm)
$86.67
Employees
7534
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2020
rev ($mm)
$15.41
EBITDA ($mm)
($7.76)
EBIT ($mm)
($7.93)
Net Income ($mm)
Employees
163
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: HAXS
 
 
 
 
 
 
 
 
Healthaxis, Inc.
Healthaxis, Inc.
HealthAxis Group is simultaneously the most experienced and modern SaaS-based supplier of benefit platform systems. The comprehensive suite offered by HealthAxis helps organizations address compliance, increase administrative efficiency, lower cost, and improve quality.
year
2007
rev ($mm)
$16.03
EBITDA ($mm)
$0.27
EBIT ($mm)
($0.86)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch